Buprenorphine patches play a crucial role in chronic pain management, bridging the gap between effective analgesia and safe opioid utilization. This market research report delves into the evolving ...

GREENFIELD, Ind.--(BUSINESS WIRE)--With the U.S. Food and Drug Administration (FDA) approval of Zorbium™ (buprenorphine transdermal solution), Elanco Animal Health (NYSE: ELAN) expands its pain ...

Buprenorphine may be as effective as conventional analgesia in older adults with acute pain, with reduced opioid consumption and breakthrough analgesia. In older adults, buprenorphine was found to ...

Patients switched from opioids to buprenorphine achieved equianalgesia with 6 mg buprenorphine or less daily regardless of baseline OME requirements. In patients receiving palliative care, pain can be ...

Buprenorphine is a prescription medication. It’s approved by the Food and Drug Administration (FDA) to treat opioid dependence in adults. Opioid dependence is also called opioid use disorder (OUD), ...

FDA Approves Methylphenidate Patch for Teens With ADHD The FDA has approved an expanded age range for a methylphenidate transdermal system for the treatment of ADHD in adolescents aged 13 to 17 years.

18.5. Alvogen, Inc. 18.6. Amneal Pharmaceuticals, Inc. 18.7. Camber Pharmaceuticals, Inc. 18.8. Indivior UK Limited 18.9. Lupin Limited 18.10. Purdue Pharma L.P. 18. ...